Published in Int J Fertil Steril on December 23, 2015
Endometriosis. Lancet (2004) 8.41
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med (2001) 6.73
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med (2002) 5.50
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A (1991) 3.95
ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod (2005) 3.55
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer (2008) 3.46
Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost (2003) 2.49
Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene (1993) 1.83
Levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod (2003) 1.61
Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases. Ann Surg Oncol (2011) 1.59
Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol (2003) 1.58
Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod (1998) 1.48
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain (2006) 1.46
Angiogenic factors in endometriosis. Ann N Y Acad Sci (2002) 1.44
Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod (1997) 1.37
Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer (2005) 1.24
Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors (1996) 1.21
Non-invasive methods of diagnosis of endometriosis. Curr Opin Obstet Gynecol (2003) 1.18
The discovery of the placental growth factor and its role in angiogenesis: a historical review. Angiogenesis (2008) 1.13
Placenta growth factor expression is correlated with survival of patients with colorectal cancer. Gut (2005) 1.12
Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet (2005) 1.10
Evidence for a relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men. PLoS One (2010) 1.01
Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents. Nutrition (2011) 0.98
Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans. J Nutr Biochem (2009) 0.98
Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril (2007) 0.97
High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata. Mol Hum Reprod (2000) 0.95
Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol (2007) 0.95
Angiogenesis and endometriosis. Obstet Gynecol Int (2013) 0.93
Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels. Anticancer Res (2004) 0.93
Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement. Br J Cancer (2010) 0.92
Transvaginal sonography for the assessment of ovarian and pelvic endometriosis: how deep is our understanding? Ultrasound Obstet Gynecol (2009) 0.90
Vasculogenesis: a new piece of the endometriosis puzzle. Hum Reprod Update (2011) 0.90
Placenta growth factor, PLGF, influences the motility of lung cancer cells, the role of Rho associated kinase, Rock1. J Cell Biochem (2008) 0.89
Noninvasive diagnosis of endometriosis: the role of imaging and markers. Obstet Gynecol Clin North Am (2003) 0.89
Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma. Oral Oncol (2012) 0.88
Elevated PLGF contributes to small-cell lung cancer brain metastasis. Oncogene (2012) 0.88
Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer. Dis Colon Rectum (2009) 0.88
Depression and BMI influences the serum vascular endothelial growth factor level. Int J Neuropsychopharmacol (2014) 0.87
Vascular endothelial growth factor signaling implicated in neuroprotective effects of placental growth factor in an in vitro ischemic model. Brain Res (2010) 0.87
Vascular endothelial growth factor (VEGF) and ovarian endometriosis: correlation between VEGF serum levels, VEGF cellular expression, and pelvic pain. Fertil Steril (2007) 0.81
Women with endometriosis have increased levels of placental growth factor in the peritoneal fluid compared with women with cystadenomas. Hum Reprod (2003) 0.80
Matrix metalloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometriosis. Gynecol Obstet Invest (2010) 0.80
Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil Steril (2009) 0.78
Vascular endothelial growth factor in the plasma, follicular fluid and granulosa cells of women with endometriosis submitted to in vitro fertilization--a pilot study. Gynecol Endocrinol (2005) 0.77
Intrahepatic Cholestasis of Pregnancy: mRNAs for LIPF and ELOVL4 Genes Are Not Detectable in Circulating Maternal Plasma. Fetal Diagn Ther (2014) 0.75
Possible Gender-Related Modulation by the ROCK1 Gene in Colorectal Cancer Susceptibility. Pathobiology (2015) 0.75